Chronic Myeloid Leukemia Treatment Discontinuation
1 Tampilan
administrator
06/27/23
The panelists, Jorge Cortes, MD; Kevin Kelly, MD, PhD; David Snyder, MD, FACP; Harry Erba, MD, PhD; and Javier Pinilla-Ibarz, MD, PhD, discuss under what conditions treatment discontinuation may be considered in the management of chronic myeloid leukemia.
Menampilkan lebih banyak
Komentar Facebook
Tidak ada komentar yang ditemukan